Compositions and methods of using chondroitinase ABCI mutants
Details for Australian Patent Application No. 2007307736 (hide)
International Classifications
Event Publications
14 May 2009 PCT application entered the National Phase
PCT publication WO2008/045970 Priority application(s): WO2008/045970
26 November 2009 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 13 Aug 2009
3 December 2009 Section 223 Application Received
Acorda Therapeutics, Inc. An application to extend the time from 16 Apr 2008 to 16 Nov 2009 in which to comply with Section 6(c) has been filed . Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden ACT 2606 2009
21 January 2010 Section 223 Application Allowed
Acorda Therapeutics, Inc. the time in which to comply with Section 6(c) has been extended to 16 Nov 2009. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden ACT 2606 2009
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2007307763-Pyrrolydine derivatives as IAP inhibitors
2007307719-Compositions and devices comrising silicone and specific polyphosphazenes
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser